Blood RNA alternative splicing events as diagnostic biomarkers for infectious disease

[1]  Rachel S. G. Sealfon,et al.  Pre-infection antiviral innate immunity contributes to sex differences in SARS-CoV-2 infection , 2022, Cell Systems.

[2]  S. Sealfon,et al.  Earlier detection of SARS‐CoV‐2 infection by blood RNA signature microfluidics assay , 2022, Clinical and translational discovery.

[3]  Michael B. Mayhew,et al.  Prospective validation of a transcriptomic severity classifier among patients with suspected acute infection and sepsis in the emergency department , 2022, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[4]  D. Buonsenso,et al.  Transcript host-RNA signatures to discriminate bacterial and viral infections in febrile children , 2021, Pediatric Research.

[5]  P. Georgiou,et al.  Discovery and validation of a three-gene signature to distinguish COVID-19 and other viral infections in emergency infectious disease presentations: a case-control and observational cohort study , 2021, The Lancet Microbe.

[6]  M. Hibberd,et al.  A blood RNA transcriptome signature for COVID-19 , 2021, BMC medical genomics.

[7]  Ricardo Henao,et al.  Discriminating Bacterial and Viral Infection Using a Rapid Host Gene Expression Test* , 2021, Critical care medicine.

[8]  Ricardo Henao,et al.  Dysregulated transcriptional responses to SARS-CoV-2 in the periphery , 2021, Nature Communications.

[9]  Rachel S. G. Sealfon,et al.  SARS-CoV-2 Transmission among Marine Recruits during Quarantine , 2020, The New England journal of medicine.

[10]  Silvio C. E. Tosatto,et al.  Pfam: The protein families database in 2021 , 2020, Nucleic Acids Res..

[11]  M. Guttman,et al.  SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses , 2020, Cell.

[12]  Ricardo Henao,et al.  A blood-based host gene expression assay for early detection of respiratory viral infection: an index-cluster prospective cohort study , 2020, The Lancet Infectious Diseases.

[13]  Inkyung Jung,et al.  Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 , 2020, Science Immunology.

[14]  Konrad U. Förstner,et al.  Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients , 2020, Genome Medicine.

[15]  Yudong D. He,et al.  Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections , 2020, iScience.

[16]  S. Cherry,et al.  Viral-induced alternative splicing of host genes promotes influenza replication , 2020, bioRxiv.

[17]  L. Kucirka,et al.  Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.

[18]  D. Black,et al.  Deep-learning augmented RNA-seq analysis of transcript splicing , 2019, Nature Methods.

[19]  Yingnian Wu,et al.  Deep-learning augmented RNA-seq analysis of transcript splicing , 2019, Nature Methods.

[20]  Olga G. Troyanskaya,et al.  GIANT 2.0: genome-scale integrated analysis of gene networks in tissues , 2018, Nucleic Acids Res..

[21]  Miha Skalic,et al.  SUPPA2: fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions , 2016, Genome Biology.

[22]  Huanming Yang,et al.  Characterization of viral RNA splicing using whole-transcriptome datasets from host species , 2018, Scientific Reports.

[23]  Manuel D. Díaz-Muñoz,et al.  RNA-binding proteins control gene expression and cell fate in the immune system , 2018, Nature Immunology.

[24]  Y. Xing,et al.  The Expanding Landscape of Alternative Splicing Variation in Human Populations , 2018, American journal of human genetics.

[25]  Arul M. Chinnaiyan,et al.  Cancer transcriptome profiling at the juncture of clinical translation , 2017, Nature Reviews Genetics.

[26]  Gene W. Yeo,et al.  A Large-Scale Binding and Functional Map of Human RNA Binding Proteins , 2017, bioRxiv.

[27]  Annalisa Schaub,et al.  Splicing in immune cells—mechanistic insights and emerging topics , 2017, International immunology.

[28]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[29]  Daniel S. Himmelstein,et al.  Understanding multicellular function and disease with human tissue-specific networks , 2015, Nature Genetics.

[30]  Boqin Hu,et al.  CLIPdb: a CLIP-seq database for protein-RNA interactions , 2015, BMC Genomics.

[31]  Lan Lin,et al.  rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data , 2014, Proceedings of the National Academy of Sciences.

[32]  K. Lynch,et al.  Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn , 2013, Immunological reviews.

[33]  Emily K. Schutsky,et al.  The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A. , 2012, Journal of molecular biology.

[34]  L. Carin,et al.  Temporal Dynamics of Host Molecular Responses Differentiate Symptomatic and Asymptomatic Influenza A Infection , 2011, PLoS genetics.

[35]  Matko Bosnjak,et al.  REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms , 2011, PloS one.

[36]  J. Harrow,et al.  GENCODE: producing a reference annotation for ENCODE , 2006, Genome Biology.

[37]  F. Hentges,et al.  LST1: A Gene with Extensive Alternative Splicing and Immunomodulatory Function1 , 2000, The Journal of Immunology.

[38]  C. Duckett,et al.  iPABP, an inducible poly(A)-binding protein detected in activated human T cells , 1995, Molecular and cellular biology.

[39]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..